immunotherapy in stage iii nsclc metastatic disease
Published 2 years ago • 181 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:22
moving immunotherapy to earlier lines in nsclc
-
7:44
immunotherapy in stage iii nsclc
-
5:03
immunotherapy in metastatic nsclc
-
1:00
combining sabr and immunotherapies for nsclc
-
7:44
immunotherapy in stage iii nsclc
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
53:49
the role of immunotherapy in late stage nsclc webinar
-
1:52
is adjuvant immunotherapy necessary in non-small cell lung cancer?
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
2:12
dr. hanna on consolidation immunotherapy in stage iii nsclc
-
2:20
dr. antonia on investigational immunotherapy combinations in stage iii nsclc
-
1:54
dr. gainor on the pacific-2 trial in stage iii nsclc
-
5:59
durvalumab in stage iii nsclc based on performance status
-
6:20
immunotherapy in stage iii nsclc: practice-changing results of pacific trial (bmic-006)
-
1:06
improving outcomes for patients with metastatic nsclc with immunotherapy
-
9:57
practical considerations for immunotherapy in stage 3 nsclc
-
4:37
immunotherapy in early stage nsclc
-
5:17
immunotherapy in stage iii nsclc - case based panel discussion